CDH2 and breast carcinoma: To investigate the effect of the bone microenvironment on patient-derived breast cancer cells' invasiveness, we analyzed their mRNA levels related to EMT/MET biomarkers such as E-cadherin and N-cadherin and compared our results with cells grown on a 2D surface.